Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (1491-1500 of 9,628) with videos related to

Pageof 963
Sort By:
Leukemia|January 22, 2013
Src kinase-induced phosphorylation of annexin A2 mediates glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemiaJ A P Spijkers-Hagelstein, S Mimoso Pinhanços, P Schneider, et al.
Leukemia|January 15, 2013
Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantationT Schroeder, A Czibere, U Platzbecker, et al.
Leukemia|January 16, 2013
Inhibition of intracellular dipeptidyl peptidases 8 and 9 enhances parthenolide's anti-leukemic activityP A Spagnuolo, R Hurren, M Gronda, et al.
Leukemia|January 17, 2013
A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapseS Park, N Chapuis, F Saint Marcoux, et al.
Leukemia|February 16, 2013
Genome-wide profiling reveals epigenetic inactivation of the PU.1 pathway by histone H3 lysine 27 trimethylation in cytogenetically normal myelodysplastic syndromeJ X Cheng, J Anastasi, K Watanabe, et al.
Leukemia|February 19, 2013
Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinibF Efficace, M Baccarani, M Breccia, et al.
Leukemia|March 5, 2013
Notch signaling in acute promyelocytic leukemiaNicole R Grieselhuber, Jeffery M Klco, Angela M Verdoni, et al.
Leukemia|April 19, 2013
Age, JAK2(V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosisJ Broséus, T Alpermann, M Wulfert, et al.
Leukemia|April 23, 2013
CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemiaA Pardanani, T L Lasho, R R Laborde, et al.
Leukemia|April 24, 2013
Loss of p53 and altered miR15-a/16-1MCL-1 pathway in CLL: insights from TCL1-Tg:p53(-/-) mouse model and primary human leukemia cellsJ Liu, G Chen, L Feng, et al.
Pageof 963

Showing results (1491-1500 of 9,628) with videos related to

Sort By:
Pageof 963
Leukemia|January 22, 2013
Src kinase-induced phosphorylation of annexin A2 mediates glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemiaJ A P Spijkers-Hagelstein, S Mimoso Pinhanços, P Schneider, et al.
Leukemia|January 15, 2013
Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantationT Schroeder, A Czibere, U Platzbecker, et al.
Leukemia|January 16, 2013
Inhibition of intracellular dipeptidyl peptidases 8 and 9 enhances parthenolide's anti-leukemic activityP A Spagnuolo, R Hurren, M Gronda, et al.
Leukemia|January 17, 2013
A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapseS Park, N Chapuis, F Saint Marcoux, et al.
Leukemia|February 16, 2013
Genome-wide profiling reveals epigenetic inactivation of the PU.1 pathway by histone H3 lysine 27 trimethylation in cytogenetically normal myelodysplastic syndromeJ X Cheng, J Anastasi, K Watanabe, et al.
Leukemia|February 19, 2013
Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinibF Efficace, M Baccarani, M Breccia, et al.
Leukemia|March 5, 2013
Notch signaling in acute promyelocytic leukemiaNicole R Grieselhuber, Jeffery M Klco, Angela M Verdoni, et al.
Leukemia|April 19, 2013
Age, JAK2(V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosisJ Broséus, T Alpermann, M Wulfert, et al.
Leukemia|April 23, 2013
CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemiaA Pardanani, T L Lasho, R R Laborde, et al.
Leukemia|April 24, 2013
Loss of p53 and altered miR15-a/16-1MCL-1 pathway in CLL: insights from TCL1-Tg:p53(-/-) mouse model and primary human leukemia cellsJ Liu, G Chen, L Feng, et al.
Pageof 963